DOCSLIB.ORG

Advances in Immunology Associate Editors

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

UCLA UCLA Previously Published Works Title Advances in PET Detection of the Antitumor T Cell Response. Permalink https://escholarship.org/uc/item/4xj2w70k Authors McCracken, MN Tavaré, R Witte, ON et al. Publication Date 2016 DOI 10.1016/bs.ai.2016.02.004 Peer reviewed eScholarship.org Powered by the California Digital Library University of California VOLUME ONE HUNDRED AND THIRTY ONE ADVANCES IN IMMUNOLOGY ASSOCIATE EDITORS K. Frank Austen Harvard Medical School, Boston, Massachusetts, USA Tasuku Honjo Kyoto University, Kyoto, Japan Fritz Melchers University of Basel, Basel, Switzerland Hidde Ploegh Massachusetts Institute of Technology, Massachusetts, USA Kenneth M. Murphy Washington University, St. Louis, Missouri, USA VOLUME ONE HUNDRED AND THIRTY ONE ADVANCES IN IMMUNOLOGY Edited by FREDERICK W. ALT Howard Hughes Medical Institute, Boston, Massachusetts, USA AMSTERDAM • BOSTON • HEIDELBERG • LONDON NEW YORK • OXFORD • PARIS • SAN DIEGO SAN FRANCISCO • SINGAPORE • SYDNEY • TOKYO Academic Press is an imprint of Elsevier Academic Press is an imprint of Elsevier 50 Hampshire Street, 5th Floor, Cambridge, MA 02139, USA 525 B Street, Suite 1800, San Diego, CA 92101-4495, USA The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, UK 125 London Wall, London, EC2Y 5AS, UK First edition 2016 © 2016 Elsevier Inc. All rights reserved No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval system, without permission in writing from the publisher. Details on how to seek permission, further information about the Publisher’s permissions policies and our arrangements with organizations such as the Copyright Clearance Center and the Copyright Licensing Agency, can be found at our website: www.elsevier.com/permissions. This book and the individual contributions contained in it are protected under copyright by the Publisher (other than as may be noted herein). Notices Knowledge and best practice in this field are constantly changing. As new research and experience broaden our understanding, changes in research methods, professional practices, or medical treatment may become necessary. Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any information, methods, compounds, or experiments described herein. In using such information or methods they should be mindful of their own safety and the safety of others, including parties for whom they have a professional responsibility. To the fullest extent of the law, neither the Publisher nor the authors, contributors, or editors, assume any liability for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. ISBN: 978-0-12-804798-9 ISSN: 0065-2776 For information on all Academic Press publications visit our website at https://www.elsevier.com/ Publisher: Zoe Kruze Acquisition Editor: Mary Zimmerman Editorial Project Manager: Helene Kabes Production Project Manager: Surya Narayanan Jayachandran Designer: Greg Harris Typeset by SPi Global, India CONTENTS Contributors vii 1. Malondialdehyde Epitopes as Targets of Immunity and the Implications for Atherosclerosis 1 N. Papac-Milicevic, C.J.-L. Busch, and C.J. Binder 1. Overview 2 2. Biochemistry and Generation of MDA In Vitro and In Vivo 2 3. Generation of MDA Epitopes 5 4. Carriers of MDA Epitopes 10 5. Targets of Immune Response 20 6. Innate Immune Responses Toward OSEs 20 7. Adaptive Immunity Responses on MDA Epitopes 32 8. MDA Epitopes in Diseases 33 9. Relevance of OSEs in Cardiovascular Disease 35 10. MDA Epitopes in Atherosclerosis 36 11. MDA Epitopes as Therapeutic Targets in Cardiovascular Disease 43 12. Conclusions 45 References 45 2. Factors That Regulate the Generation of Antibody-Secreting Plasma Cells 61 Y.-H. Yu and K.-I. Lin 1. Germinal Center 62 2. Plasma Cells 66 3. Memory B Cells 71 4. Blimp-1 Is a Key Regulator of Plasma-Cell Differentiation 76 5. Perspectives 86 Acknowledgments 87 References 87 3. Deep Profiling Human T Cell Heterogeneity by Mass Cytometry 101 Y. Cheng and E.W. Newell 1. Introduction 102 2. T Cell Heterogeneity: Days of Future Past 104 3. Mass Cytometry: Experimental Workflow and Data Processing 107 4. Mass Cytometry: Panel Design for T Cell Analysis 113 v vi Contents 5. Probing T Cell Specificity: From Single to Multiplex Tetramer 119 6. Dissecting Mass Cytometry Data: High-Dimensional Data Analysis 121 7. Future Perspectives 126 8. Concluding Remarks 127 Acknowledgments 128 References 128 4. Germinal Center B-Cell-Associated Nuclear Protein (GANP) Involved in RNA Metabolism for B Cell Maturation 135 N. Sakaguchi and K. Maeda 1. Introduction 136 2. Affinity Maturation and Ab Specificity 138 3. Molecules Associated with Ab Affinity Maturation 140 4. Germinal Center B-Cell-Associated Nuclear Protein 145 5. Structure of GANP 151 6. GANP-Associated Proteins 156 7. Transcription-Coupled IgV Region SHM 163 8. TREX-2 and Diseases 167 9. Perspectives 170 Acknowledgments 170 References 171 5. Advances in PET Detection of the Antitumor T Cell Response 187 M.N. McCracken, R. Tavaré, O.N. Witte, and A.M. Wu 1. Introduction 188 2. Ex Vivo Cell Labeling for Tracking Immune Cells In Vivo 192 3. Small Molecule Metabolite Probes for Tracking T Cells 196 4. PET Reporter Imaging for Tracking Engineered Cells In Vivo 202 5. In Vivo Detection of Immune Cells Using Radiolabeled Proteins 211 6. Concluding Remarks and Future Direction of PET Imaging the Antitumor T Cell Response 221 Acknowledgments 222 References 222 Index 233 Contents of Recent Volumes 237 CONTRIBUTORS C.J. Binder Medical University of Vienna; Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences, Vienna, Austria C.J.-L. Busch Medical University of Vienna; Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences, Vienna, Austria Y. Cheng Singapore Immunology Network, Agency of Science, Technology and Research; School of Biological Science, Nanyang Technological University, Singapore, Singapore K.-I. Lin Genomics Research Center, Academia Sinica, Taipei, Taiwan K. Maeda WPI Immunology Frontier Research Center (IFReC); Laboratory of Host Defense, Research Institute for Microbial Diseases, Osaka University, Suita, Japan M.N. McCracken Institute for Stem Cell Biology and Regenerative Medicine; Ludwig Center for Cancer Stem Cell Research and Medicine; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, United States E.W. Newell Singapore Immunology Network, Agency of Science, Technology and Research; School of Biological Science, Nanyang Technological University, Singapore, Singapore N. Papac-Milicevic Medical University of Vienna; Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences, Vienna, Austria N. Sakaguchi WPI Immunology Frontier Research Center (IFReC), Osaka University, Suita, Osaka; Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan R. Tavare´ Crump Institute for Molecular Imaging, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States O.N. Witte Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine; Molecular Biology Institute; Howard Hughes Medical Institute, UCLA, Los Angeles, CA, United States A.M. Wu Crump Institute for Molecular Imaging; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States Y.-H. Yu Genomics Research Center, Academia Sinica, Taipei, Taiwan vii This page intentionally left blank CHAPTER ONE Malondialdehyde Epitopes as Targets of Immunity and the Implications for Atherosclerosis N. Papac-Milicevic*,†,1, C.J.-L. Busch*,†,1, C.J. Binder*,†,2 *Medical University of Vienna, Vienna, Austria †Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences, Vienna, Austria 2Corresponding author: e-mail address: [email protected] Contents 1. Overview 2 2. Biochemistry and Generation of MDA In Vitro and In Vivo 2 3. Generation of MDA Epitopes 5 3.1 MDA Modification of Amino Acids and Proteins 6 3.2 MDA Modification of Nucleotides and Nucleic Acids 8 3.3 MDA Modification of Phospholipids 9 3.4 Metabolism of MDA Epitopes In Vivo 10 4. Carriers of MDA Epitopes 10 5. Targets of Immune Response 20 6. Innate Immune Responses Toward OSEs 20 6.1 Cellular Receptors of MDA Epitopes 22 6.2 Proinflammatory Effects of MDA Epitopes 24 6.3 Innate Recognition by IgM Natural Antibodies and Complement 26 7. Adaptive Immunity Responses on MDA Epitopes 32 8. MDA Epitopes in Diseases 33 9. Relevance of OSEs in Cardiovascular Disease 35 10. MDA Epitopes in Atherosclerosis 36 10.1 MDA Immunization Protects from Atherosclerosis 38 10.2 MDA-Specific Natural Immunity Protects from Atherosclerosis 41 11. MDA Epitopes as Therapeutic Targets in Cardiovascular Disease 43 12. Conclusions 45 References 45 Abstract Accumulating evidence suggests that oxidation-specific epitopes (OSEs) constitute a novel class of damage-associated molecular patterns (DAMPs) generated during high oxi- dative stress but also in the physiological process of apoptosis. To deal with the potentially 1 Contributed equally. Advances in Immunology, Volume 131 # 2016 Elsevier Inc. 1 ISSN 0065-2776 All rights reserved. http://dx.doi.org/10.1016/bs.ai.2016.02.001
Recommended publications
  • Human Prion-Like Proteins and Their Relevance in Disease

    Human Prion-Like Proteins and Their Relevance in Disease

    ADVERTIMENT. Lʼaccés als continguts dʼaquesta tesi queda condicionat a lʼacceptació de les condicions dʼús establertes per la següent llicència Creative Commons: http://cat.creativecommons.org/?page_id=184 ADVERTENCIA. El acceso a los contenidos de esta tesis queda condicionado a la aceptación de las condiciones de uso establecidas por la siguiente licencia Creative Commons: http://es.creativecommons.org/blog/licencias/ WARNING. The access to the contents of this doctoral thesis it is limited to the acceptance of the use conditions set by the following Creative Commons license: https://creativecommons.org/licenses/?lang=en Universitat Autònoma de Barcelona Departament de Bioquímica i Biologia Molecular Institut de Biotecnologia i Biomedicina HUMAN PRION-LIKE PROTEINS AND THEIR RELEVANCE IN DISEASE Doctoral thesis presented by Cristina Batlle Carreras for the degree of PhD in Biochemistry, Molecular Biology and Biomedicine from the Universitat Autònoma de Barcelona. The work described herein has been performed in the Department of Biochemistry and Molecular Biology and in the Institute of Biotechnology and Biomedicine, supervised by Prof. Salvador Ventura i Zamora. Cristina Batlle Carreras Prof. Salvador Ventura i Zamora Bellaterra, 2020 Protein Folding and Conformational Diseases Lab. This work was financed with the fellowship “Formación de Profesorado Universitario” by “Ministerio de Ciencia, Innovación y Universidades”. This work is licensed under a Creative Commons Attributions-NonCommercial-ShareAlike 4.0 (CC BY-NC- SA 4.0) International License. The extent of this license does not apply to the copyrighted publications and images reproduced with permission. (CC BY-NC-SA 4.0) Batlle, Cristina: Human prion-like proteins and their relevance in disease. Doctoral Thesis, Universitat Autònoma de Barcelona (2020) English summary ENGLISH SUMMARY Prion-like proteins have attracted significant attention in the last years.
  • Development of VHH- and Antibody- Based

    Development of VHH- and Antibody- Based

    Development of VHH- and Antibody- based Imaging and Diagnostic Tools by Zeyang Li Bachelor of Science in Biochemistry University of Wisconsin-Madison, WI, 2011 Submitted to the Department of Chemistry In Partial Fulfilment of the requirement for the Degree of Doctor of Philosophy at the Massachusetts Institute of Technology June 2018 2018 Massachusetts Institute of Technology All rights reserved Signature redacted Signature of Author........ Department of Chemistry 21 May 2018 Certified by.....................Signature redacted Hidde Ploegh OF TECHNOLOGY Senior Investigator Program in Cellular and Molecular Medicine JUN 2 0 Z018 At Boston Children's Hospital LIBRARIES ARCHIVES Signature redacted A cce pted by ....... .......................................... Robert W. Field Haslam and Dewey Professor of Chemistry Chairman, Departmental Committee for Graduate students This doctoral thesis has been examined by a committee of the Department of Chemistry as follows: ............................Signature redacted ----- Barbara Imperiali Class of 1922 Professor of Biology and Chemistry MacVicar Faculty Fellow Thesis Committee Chair Signature redacted Hidde Ploegh Senior Investigator Program in Cellular and Molecular Medicine Boston Children's Hospital / Z" Thes;Supervisor Signature redacted Bradley L. Pentelute Pfizer-Laubach Career Development Professor of Chemistry Abstract The immune system distinguishes self from non-self to combat pathogenic incursions. Evasion tactics deployed by viruses, microbes, or malignant cells may impede an adequate response. In such cases, therapeutic interventions aid in the elimination of pathogens and the restoration of physiological homeostasis. A major road block in the development of such therapies is the reliance on imperfect detection methods to identify site(s) of infection, or to monitor immune cell recruitment to sites of infection or inflammation in vivo.
  • Unique Epitopes on Cεmx in Ige–B Cell Receptors Are Potentially Applicable for Targeting Ige-Committed B Cells

    Unique Epitopes on Cεmx in Ige–B Cell Receptors Are Potentially Applicable for Targeting Ige-Committed B Cells

    Unique Epitopes on CεmX in IgE−B Cell Receptors Are Potentially Applicable for Targeting IgE-Committed B Cells This information is current as Jiun-Bo Chen, Pheidias C. Wu, Alfur Fu-Hsin Hung, of October 1, 2021. Chia-Yu Chu, Tsen-Fang Tsai, Hui-Ming Yu, Hwan-You Chang and Tse Wen Chang J Immunol 2010; 184:1748-1756; Prepublished online 18 January 2010; doi: 10.4049/jimmunol.0902437 http://www.jimmunol.org/content/184/4/1748 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2010/01/13/jimmunol.090243 Material 7.DC1 http://www.jimmunol.org/ References This article cites 52 articles, 19 of which you can access for free at: http://www.jimmunol.org/content/184/4/1748.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on October 1, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2010 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Unique Epitopes on C«mX in IgE–B Cell Receptors Are Potentially Applicable for Targeting IgE-Committed B Cells Jiun-Bo Chen,*,† Pheidias C.
  • S1 Supplemental Materials Supplemental Methods Supplemental Figure 1. Immune Phenotype of Mcd19 Targeted CAR T and Dose Titratio

    S1 Supplemental Materials Supplemental Methods Supplemental Figure 1. Immune Phenotype of Mcd19 Targeted CAR T and Dose Titratio

    Supplemental Materials Supplemental Methods Supplemental Figure 1. Immune phenotype of mCD19 targeted CAR T and dose titration of in vivo efficacy. Supplemental Figure 2. Gene expression of fluorescent-protein tagged CAR T cells. Supplemental Figure 3. Fluorescent protein tagged CAR T cells function similarly to non-tagged counterparts. Supplemental Figure 4. Transduction efficiency and immune phenotype of mCD19 targeted CAR T cells for survival study (Figure 2D). Supplemental Figure 5. Transduction efficiency and immune phenotype of CAR T cells used in irradiated CAR T study (Fig. 3B-C). Supplemental Figure 6. Differential gene expression of CD4+ m19-humBBz CAR T cells. Supplemental Figure 7. CAR expression and CD4/CD8 subsets of human CD19 targeted CAR T cells for Figure 5E-G. Supplemental Figure 8. Transduction efficiency and immune phenotype of mCD19 targeted wild type (WT) and TRAF1-/- CAR T cells used for in vivo study (Figure 6D). Supplemental Figure 9. Mutated m19-musBBz CAR T cells have increased NF-κB signaling, improved cytokine production, anti-apoptosis, and in vivo function. Supplemental Figure 10. TRAF and CAR co-expression in human CD19-targeted CAR T cells. Supplemental Figure 11. TRAF2 over-expressed h19BBz CAR T cells show similar in vivo efficacy to h19BBz CAR T cells in an aggressive leukemia model. S1 Supplemental Table 1. Probesets increased in m19z and m1928z vs m19-musBBz CAR T cells. Supplemental Table 2. Probesets increased in m19-musBBz vs m19z and m1928z CAR T cells. Supplemental Table 3. Probesets differentially expressed in m19z vs m19-musBBz CAR T cells. Supplemental Table 4. Probesets differentially expressed in m1928z vs m19-musBBz CAR T cells.
  • World Premier International Research Center Initiative (WPI) Executive Summary (For Extension Application Screening)

    World Premier International Research Center Initiative (WPI) Executive Summary (For Extension Application Screening)

    World Premier International Research Center Initiative (WPI) Executive Summary (For Extension application screening) Host Institution Osaka University Host Institution Head Toshio Hirano Research Center Immunology Frontier Research Center Center Director Shizuo Akira A. Progress Report of the WPI Center I. Summary In 2007, IFReC set out to integrate imaging and informatics technologies with immunology (IFReC’s three Is), aiming to unveil spatio-temporal and collective behavior of immune cells and molecules in vivo for comprehensive understanding of immune dynamism. While overcoming intellectual and technical perplexities encountered at early stages in collaboration of researchers in different fields or with different backgrounds, through strategical establishment of platforms for such interdisciplinary research, our all-out effort has ultimately resulted in a number of immunologically important discoveries as well as publication of more than 800 papers with an average number of citations of 29.2. Above all, new insight into the immune-regulating mechanism is the foremost achievement attained so fa r, w hich is expected to produce new seeds of clinical immunology for diagnosis, therapy and prevention of immune-related diseases. II. Items 1. Overall Image of Your Center IFReC has become a globally visible stronghold of top-class immunologists, and imaging and informatics researchers, rallying to comprehensively understand immune dynamism, while advancing frontier researches in their own fields. Considering the spacious laboratories, animal resource facilities, and instalment of highly advanced instruments, the entire research environment of IFReC is of the highest international level. The research support/administration system is also arranged for smooth and effective operation, enabling IFReC researchers to concentrate on research as well as supporting overseas researchers.
  • Proteogenomic Analysis of Inhibitor of Differentiation 4 (ID4) in Basal-Like Breast Cancer Laura A

    Proteogenomic Analysis of Inhibitor of Differentiation 4 (ID4) in Basal-Like Breast Cancer Laura A

    Baker et al. Breast Cancer Research (2020) 22:63 https://doi.org/10.1186/s13058-020-01306-6 RESEARCH ARTICLE Open Access Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer Laura A. Baker1,2, Holly Holliday1,2†, Daniel Roden1,2†, Christoph Krisp3,4†, Sunny Z. Wu1,2, Simon Junankar1,2, Aurelien A. Serandour5, Hisham Mohammed5, Radhika Nair6, Geetha Sankaranarayanan5, Andrew M. K. Law1,2, Andrea McFarland1, Peter T. Simpson7, Sunil Lakhani7,8, Eoin Dodson1,2, Christina Selinger9, Lyndal Anderson9,10, Goli Samimi11, Neville F. Hacker12, Elgene Lim1,2, Christopher J. Ormandy1,2, Matthew J. Naylor13, Kaylene Simpson14,15, Iva Nikolic14, Sandra O’Toole1,2,9,10, Warren Kaplan1, Mark J. Cowley1,2, Jason S. Carroll5, Mark Molloy3 and Alexander Swarbrick1,2* Abstract Background: Basal-like breast cancer (BLBC) is a poorly characterised, heterogeneous disease. Patients are diagnosed with aggressive, high-grade tumours and often relapse with chemotherapy resistance. Detailed understanding of the molecular underpinnings of this disease is essential to the development of personalised therapeutic strategies. Inhibitor of differentiation 4 (ID4) is a helix-loop-helix transcriptional regulator required for mammary gland development. ID4 is overexpressed in a subset of BLBC patients, associating with a stem-like poor prognosis phenotype, and is necessary for the growth of cell line models of BLBC through unknown mechanisms. Methods: Here, we have defined unique molecular insights into the function of ID4 in BLBC and the related disease high-grade serous ovarian cancer (HGSOC), by combining RIME proteomic analysis, ChIP-seq mapping of genomic binding sites and RNA-seq.
  • Cell Biology from an Immune Perspective in This Lecture We Will

    Cell Biology from an Immune Perspective in This Lecture We Will

    Harvard-MIT Division of Health Sciences and Technology HST.176: Cellular and Molecular Immunology Course Director: Dr. Shiv Pillai Cell Biology from an Immune Perspective In this lecture we will very briefly review some aspects of cell biology which are required as background knowledge in order to understand how the immune system works. These will include: 1. A brief overview of protein trafficking 2. Signal transduction 3. The cell cycle Some of these issues will be treated in greater depth in later lectures. Protein Trafficking/The Secretory Pathway: From an immune perspective the secretory compartment and structures enclosed by vesicles are “seen” in different ways from proteins that reside in the cytosol or the nucleus. We will briefly review the secretory and endocytic pathways and discuss the biogenesis of membrane proteins. Some of the issues that will be discussed are summarized in Figures 1-3. Early endosomes Late endosomes Lysosomes Golgi Vesiculo-Tubular Compartment ER Figure 1. An overview of the secretory pathway Early endosomes Late endosomes Multivesicular and multilamellar bodies Golgi ER Proteasomes Figure 2. Protein degradation occurs mainly in lysosomes and proteasomes Proteins that enter the cell from the environment are primarily degraded in lysosomes. Most cytosolic and nuclear proteins are degraded in organelles called proteasomes. Intriguingly these two sites of degradation are each functionally linked to distinct antigen presentation pathways, different kinds of MHC molecules and the activation of different categories of T cells. Integral membrane proteins maybe inserted into the membrane in a number of ways, the two most common of these ways being considered in Figure 3.
  • Optimized Fluorescent Labeling to Identify Memory B Cells Specific for Neisseria Meningitidis Serogroup B Vaccine Antigens Ex Vivo

    Optimized Fluorescent Labeling to Identify Memory B Cells Specific for Neisseria Meningitidis Serogroup B Vaccine Antigens Ex Vivo

    Optimized fluorescent labeling to identify memory B cells specific for Neisseria meningitidis serogroup B vaccine antigens ex vivo The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Nair, Nitya, Ludovico Buti, Elisa Faenzi, Francesca Buricchi, Sandra Nuti, Chiara Sammicheli, Simona Tavarini, et al. “ Optimized Fluorescent Labeling to Identify Memory B Cells Specific for Neisseria Meningitidis Serogroup B Vaccine Antigens Ex Vivo .” Immun. Inflamm. Dis. 1, no. 1 (October 2013): 3–13. As Published http://dx.doi.org/10.1002/iid3.3 Publisher Wiley Blackwell Version Final published version Citable link http://hdl.handle.net/1721.1/92523 Terms of Use Creative Commons Attribution Detailed Terms http://creativecommons.org/licenses/by/3.0/ ORIGINAL RESEARCH Optimized fluorescent labeling to identify memory B cells specific for Neisseria meningitidis serogroup B vaccine antigens ex vivo Nitya Nair1†, Ludovico Buti1,2‡, Elisa Faenzi1, Francesca Buricchi1, Sandra Nuti1, Chiara Sammicheli1, Simona Tavarini1, Maximilian W.L. Popp2,3,4, Hidde Ploegh2,4, Francesco Berti1, Mariagrazia Pizza1, Flora Castellino1, Oretta Finco1, Rino Rappuoli1, Giuseppe Del Giudice1, Grazia Galli1, & Monia Bardelli1 1Novartis Vaccines & Diagnostics, Siena, Italy 2Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 3University of Rochester, School of Medicine & Dentistry, Rochester, New York 4Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts Keywords Abstract Antigen-specific memory B cells, flow cytometry, Neisseria meningitidis MenB, Antigen-specific memory B cells generate anamnestic responses and high affinity sortagging, vaccination antibodies upon re-exposure to pathogens. Attempts to isolate rare antigen- specific memory B cells for in-depth functional analysis at the single-cell level have Correspondence been hindered by the lack of tools with adequate sensitivity.
  • Tyr1 Phosphorylation Promotes Phosphorylation of Ser2 on the C-Terminal Domain

    Tyr1 Phosphorylation Promotes Phosphorylation of Ser2 on the C-Terminal Domain

    1 Tyr1 phosphorylation promotes phosphorylation of Ser2 on the C-terminal domain 2 of eukaryotic RNA polymerase II by P-TEFb 3 Joshua E. Mayfield1† *, Seema Irani2*, Edwin E. Escobar3, Zhao Zhang4, Nathanial T. 4 Burkholder1, Michelle R. Robinson3, M. Rachel Mehaffey3, Sarah N. Sipe3,Wanjie Yang1, 5 Nicholas A. Prescott1, Karan R. Kathuria1, Zhijie Liu4, Jennifer S. Brodbelt3, Yan Zhang1,5 6 1 Department of Molecular Biosciences, 2Department of Chemical Engineering, 7 3 Department of Chemistry and 5 Institute for Cellular and Molecular Biology, University of 8 Texas, Austin 9 4 Department of Molecular Medicine, Institute of Biotechnology, University of Texas 10 Health Science Center at San Antonio 11 †Current Address: Department of Pharmacology, University of California, San Diego, La 12 Jolla 13 * These authors contributed equally to this paper. 14 Correspondence: Yan Zhang ([email protected]) 15 16 1 17 Summary 18 The Positive Transcription Elongation Factor b (P-TEFb) phosphorylates 19 Ser2 residues of C-terminal domain (CTD) of the largest subunit (RPB1) of RNA 20 polymerase II and is essential for the transition from transcription initiation to 21 elongation in vivo. Surprisingly, P-TEFb exhibits Ser5 phosphorylation activity in 22 vitro. The mechanism garnering Ser2 specificity to P-TEFb remains elusive and 23 hinders understanding of the transition from transcription initiation to elongation. 24 Through in vitro reconstruction of CTD phosphorylation, mass spectrometry 25 analysis, and chromatin immunoprecipitation sequencing (ChIP-seq) analysis, we 26 uncover a mechanism by which Tyr1 phosphorylation directs the kinase activity of 27 P-TEFb and alters its specificity from Ser5 to Ser2.
  • Adracalin (AAAS) Rabbit Polyclonal Antibody – TA349454 | Origene

    Adracalin (AAAS) Rabbit Polyclonal Antibody – TA349454 | Origene

    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for TA349454 Adracalin (AAAS) Rabbit Polyclonal Antibody Product data: Product Type: Primary Antibodies Applications: IHC, WB Recommended Dilution: ELISA: 1000-2000, WB: 200-1000, IHC: 50-200 Reactivity: Human, Mouse Host: Rabbit Isotype: IgG Clonality: Polyclonal Immunogen: Fusion protein of human AAAS Formulation: pH7.4 PBS, 0.05% NaN3, 40% Glyceroln Concentration: lot specific Purification: Antigen affinity purification Conjugation: Unconjugated Storage: Store at -20°C as received. Stability: Stable for 12 months from date of receipt. Predicted Protein Size: 60 kDa Gene Name: aladin WD repeat nucleoporin Database Link: NP_056480 Entrez Gene 223921 MouseEntrez Gene 8086 Human Q9NRG9 Background: The protein encoded by this gene is a member of the WD-repeat family of regulatory proteins and may be involved in normal development of the peripheral and central nervous system. The encoded protein is part of the nuclear pore complex and is anchored there by NDC1. Defects in this gene are a cause of achalasia-addisonianism-alacrima syndrome (AAAS), also called triple-A syndrome or Allgrove syndrome. Two transcript variants encoding different isoforms have been found for this gene. Synonyms: AAA; AAASb; ADRACALA; ADRACALIN; ALADIN; GL003 This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021
  • Contents Research Illuminating the Interplay of Cancer and the Immune System July 2013 � Volume 1 � Issue 1

    Contents Research Illuminating the Interplay of Cancer and the Immune System July 2013 Volume 1 Issue 1

    Cancer Immunology Contents Research Illuminating the Interplay of Cancer and the Immune System July 2013 Volume 1 Issue 1 ANNOUNCEMENT CANCER IMMUNOLOGY MINIATURES 1 An Exciting Collaboration between 26 T Cells Expressing Chimeric Antigen AACR and CRI Receptors Can Cause Anaphylaxis in Humans EDITORIAL Marcela V. Maus, Andrew R. Haas, Gregory L. Beatty, Steven M. Albelda, Bruce L. Levine, Xiaojun Liu, Yangbing Zhao, 2 A Message from the Founding Michael Kalos, and Carl H. June Editor-in-Chief Glenn Dranoff Synopsis: Chimeric antigen receptor–expressing T cells (CAR-T cells) represent a promising, novel MASTERS OF IMMUNOLOGY form of adoptive immunotherapy to overcome tolerance to cancer. Using an intermittent dosing 5 Logic of the Immune System schedule of autologous CAR-T cells electroporated Hidde L. Ploegh with mRNA encoding a hybrid single chain molecule comprising the extracellular domain of CANCER IMMUNOLOGY AT THE murine monoclonal antibody against human mesothelin and the human transmembrane and CROSSROADS: FUNCTIONAL GENOMICS cytoplasmic T-cell signaling domains, Maus and colleagues characterized and reported a serious 11 Getting Personal with Neoantigen- adverse event that occurred in one of four patients Based Therapeutic Cancer Vaccines receiving repeated modified T-cell infusions, with Nir Hacohen, Edward F. Fritsch, Todd A. Carter, proposed modifications to address and minimize Eric S. Lander, and Catherine J. Wu future adverse occurrence. MEETING REPORT RESEARCH ARTICLES 16 Tumor Immunology: Multidisciplinary 32 Anti-CTLA-4 Antibodies of IgG2a Science Driving Basic and Clinical Isotype Enhance Antitumor Activity Advances through Reduction of Intratumoral Bridget P. Keenan, Elizabeth M. Jaffee, and Regulatory T Cells Todd D.
  • Genome-Wide Association for Testis Weight in the Diversity Outbred Mouse Population

    Genome-Wide Association for Testis Weight in the Diversity Outbred Mouse Population

    Genome-wide association for testis weight in the diversity outbred mouse population Joshua T. Yuan, Daniel M. Gatti, Vivek M. Philip, Steven Kasparek, Andrew M. Kreuzman, Benjamin Mansky, Kayvon Sharif, et al. Mammalian Genome ISSN 0938-8990 Volume 29 Combined 5-6 Mamm Genome (2018) 29:310-324 DOI 10.1007/s00335-018-9745-8 1 23 Your article is protected by copyright and all rights are held exclusively by Springer Science+Business Media, LLC, part of Springer Nature. This e-offprint is for personal use only and shall not be self-archived in electronic repositories. If you wish to self- archive your article, please use the accepted manuscript version for posting on your own website. You may further deposit the accepted manuscript version in any repository, provided it is only made publicly available 12 months after official publication or later and provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com”. 1 23 Author's personal copy Mammalian Genome (2018) 29:310–324 https://doi.org/10.1007/s00335-018-9745-8 Genome-wide association for testis weight in the diversity outbred mouse population Joshua T. Yuan1 · Daniel M. Gatti2 · Vivek M. Philip2 · Steven Kasparek3 · Andrew M. Kreuzman4 · Benjamin Mansky4 · Kayvon Sharif4 · Dominik Taterra4 · Walter M. Taylor4 · Mary Thomas4 · Jeremy O. Ward5 · Andrew Holmes6 · Elissa J. Chesler2 · Clarissa C. Parker3,4 Received: 30 November 2017 / Accepted: 16 April 2018 / Published online: 24 April 2018 © Springer Science+Business Media, LLC, part of Springer Nature 2018 Abstract Testis weight is a genetically mediated trait associated with reproductive efficiency across numerous species.